Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Based on Phase 2 safety data (Jastreboff et al., NEJM 2023), common early adverse effects reported include: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea or constipation Reduced appetite Mild fatigue or dizziness These effects are consistent with the GLP-1 receptor agonist class and typically reflect the gut's adaptation to altered gastric emptying and hormonal signalling
It is India's No 1 Mecobalamin Inj, 2ml with IM/ IV administration
Before discussing Synjardy with a clinician, prepare your latest A1C, kidney results if available, glucose log, current medication list, allergies, recent infections, dehydration episodes, alcohol intake, surgery plans, and pregnancy or breastfeeding considerations
If you have obtained retatrutide from an unregulated source, please speak to your GP or pharmacist before using it
Five non-completers discontinued treatment due to self-perceived insufficient weight loss, while six could not take the recommended dose due to adverse effects
US$ 20.20
US$ 21.42
US$ 20.60
US$ 24.26
US$ 24.86
US$ 26.25
US$ 22.81
US$ 24.52
